Lumbard & Kellner, LLC Viatris Inc Transaction History

Lumbard & Kellner, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$9.95 - $12.27 $5.52 Million - $6.81 Million	-554,679 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$9.81 - $15.4 $188,950 - $296,619	19,261 Added 3.6%	554,679 $6.04 Million
Q4 2021 Feb 18, 2022	BUY	$12.09 - $14.68 $1.83 Million - $2.22 Million	151,177 Added 39.34%	535,418 $7.95 Million
Q3 2021 Nov 18, 2021	SELL	$13.25 - $15.13 $86,469 - $98,738	-6,526 Reduced 1.67%	384,241 $5.21 Million
Q2 2021 Aug 26, 2021	BUY	$12.97 - $16.15 $2.36 Million - $2.93 Million	181,693 Added 86.9%	390,767 $5.58 Million
Q1 2021 May 17, 2021	BUY	$13.59 - $18.54 $390,726 - $533,043	28,751 Added 15.94%	209,074 $2.8 Million
Q4 2020 Feb 11, 2021	BUY	$14.3 - $18.74 $2.58 Million - $3.38 Million	180,323 New	180,323 $3.06 Million

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Lumbard & Kellner, LLC, based on Form 13F filings with the SEC.

Stay updated on Lumbard & Kellner, LLC with notifications on news.